BR9508154A - Anticorpos que se ligam ás proteínas de tripa de inseto e uso dos mesmos - Google Patents
Anticorpos que se ligam ás proteínas de tripa de inseto e uso dos mesmosInfo
- Publication number
- BR9508154A BR9508154A BR9508154A BR9508154A BR9508154A BR 9508154 A BR9508154 A BR 9508154A BR 9508154 A BR9508154 A BR 9508154A BR 9508154 A BR9508154 A BR 9508154A BR 9508154 A BR9508154 A BR 9508154A
- Authority
- BR
- Brazil
- Prior art keywords
- antibodies
- bind
- insect gut
- use insect
- proteins
- Prior art date
Links
- 241000238631 Hexapoda Species 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6843—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6845—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a cytokine, e.g. growth factors, VEGF, TNF, a lymphokine or an interferon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6849—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
- C07K14/325—Bacillus thuringiensis crystal protein (delta-endotoxin)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8286—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26764194A | 1994-06-28 | 1994-06-28 | |
PCT/IB1995/000497 WO1996000783A1 (en) | 1994-06-28 | 1995-06-20 | Antibodies which bind to insect gut proteins and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9508154A true BR9508154A (pt) | 1998-07-14 |
Family
ID=23019624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9508154A BR9508154A (pt) | 1994-06-28 | 1995-06-20 | Anticorpos que se ligam ás proteínas de tripa de inseto e uso dos mesmos |
Country Status (16)
Country | Link |
---|---|
US (2) | US5686600A (pt) |
EP (1) | EP0804579A1 (pt) |
JP (1) | JPH11505401A (pt) |
CN (1) | CN1151759A (pt) |
AU (1) | AU696661B2 (pt) |
BG (1) | BG101171A (pt) |
BR (1) | BR9508154A (pt) |
CA (1) | CA2193859A1 (pt) |
CZ (1) | CZ382196A3 (pt) |
EE (1) | EE9600192A (pt) |
HU (1) | HUT76089A (pt) |
MX (1) | MX9700007A (pt) |
NZ (1) | NZ287124A (pt) |
PL (1) | PL318164A1 (pt) |
SK (1) | SK166996A3 (pt) |
WO (1) | WO1996000783A1 (pt) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997029200A1 (de) * | 1996-02-08 | 1997-08-14 | Institut für Pflanzengenetik und Kulturpflanzenforschung | Kassetten zur expression von lagerstabilen proteinen in pflanzen |
WO1998044137A2 (en) * | 1997-04-03 | 1998-10-08 | Novartis Ag | Plant pest control |
US7011835B1 (en) | 1997-07-10 | 2006-03-14 | Research Development Foundation | Targeted destruction of pests |
US6013510A (en) * | 1997-09-25 | 2000-01-11 | Becton, Dickinson And Company | Identification of a DNA region potentially useful for the detection of Mycobacterium kansasii |
US7250494B2 (en) * | 1998-06-15 | 2007-07-31 | Biosynexus Incorporated | Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
CA2331921A1 (en) * | 1998-06-24 | 1999-12-29 | Boyce Thompson Institute For Plant Research, Inc. | A novel invertebrate intestinal mucin cdna and related products and methods |
US6187558B1 (en) | 1998-06-24 | 2001-02-13 | Boyce Thompson Institute For Plant Research, Inc. | Invertebrate intestinal mucin cDNA and related products and methods |
EP1123398B1 (en) * | 1998-10-16 | 2005-08-10 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Molecular pathogenicide mediated plant disease resistance |
WO2001058955A1 (en) * | 2000-02-10 | 2001-08-16 | Research Development Foundation | Targeted destruction of pests |
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US7465790B2 (en) * | 2000-10-09 | 2008-12-16 | Isis Innovation, Inc. | Therapeutic antibodies |
ATE513563T1 (de) | 2000-10-09 | 2011-07-15 | Isis Innovation | Therapeutische und toleranz-induzierende antikörper |
US6716421B2 (en) | 2001-03-05 | 2004-04-06 | University Of Florida Research Foundation, Inc. | Devices and methods for eliminating termite colonies |
US6969512B2 (en) | 2001-03-05 | 2005-11-29 | The University Of Florida Research Foundation, Inc. | Devices and methods for eliminating termite colonies |
US7030156B2 (en) | 2001-03-05 | 2006-04-18 | University Of Florida Research Foundation, Inc | Devices and methods for eliminating termite colonies |
EP1572866A4 (en) * | 2001-03-23 | 2008-01-16 | Syngenta Participations Ag | INSECT NUCLEAR RECEPTOR GENES AND USES THEREOF |
GB0119274D0 (en) * | 2001-08-08 | 2001-10-03 | Univ Durham | Fusion proteins for insect control |
US20040052779A1 (en) * | 2001-12-21 | 2004-03-18 | Stinson Jeffrey R. | Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
US20040063912A1 (en) * | 2002-03-15 | 2004-04-01 | The Brigham And Women's Hospital, Inc. | Central airway administration for systemic delivery of therapeutics |
US20040016004A1 (en) * | 2002-04-01 | 2004-01-22 | Raitano Arthur B. | Nucleic acid and corresponding protein entitled 238P1B2 useful in treatment and detection of cancer |
WO2003089475A2 (en) * | 2002-04-22 | 2003-10-30 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
US8025873B2 (en) * | 2002-06-20 | 2011-09-27 | Paladin Labs, Inc. | Chimeric antigens for eliciting an immune response |
US8029803B2 (en) * | 2002-06-20 | 2011-10-04 | Paladin Labs, Inc. | Chimeric antigens for eliciting an immune response |
US8007805B2 (en) * | 2003-08-08 | 2011-08-30 | Paladin Labs, Inc. | Chimeric antigens for breaking host tolerance to foreign antigens |
EP2946666B1 (en) | 2004-04-30 | 2017-11-15 | OrbusNeich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods of using same |
US20090238822A1 (en) * | 2005-10-13 | 2009-09-24 | Virexx Medical Corp. | Chimeric Hepatitis C Virus Antigens For Eliciting an Immune Response |
NZ580550A (en) * | 2007-04-21 | 2012-04-27 | Manuel Gidekel | Biofertilizer formulation |
WO2008156763A2 (en) * | 2007-06-15 | 2008-12-24 | The Board Of Trustees Of The Leland Stanford Junior University | Human neutralizing monoclonal antibodies to h5n1 influenza a virus |
CA2705289A1 (en) * | 2007-11-13 | 2009-05-22 | The Scripps Research Institute | Production of cytotoxic antibody-toxin fusion in eukaryotic algae |
EP2385955B1 (en) | 2009-01-12 | 2020-08-12 | CytomX Therapeutics, Inc. | Modified antibody compositions, methods of making and using thereof |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
EP3415010A1 (en) | 2017-06-13 | 2018-12-19 | Agrosavfe Nv | Insect-controlling polypeptides and methods |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5290914A (en) * | 1988-04-28 | 1994-03-01 | Mycogen Corporation | Hybrid diphtheria-B.t. pesticidal toxins |
US5196320A (en) * | 1989-09-20 | 1993-03-23 | Abbott Biotech, Inc. | Method of producing engineered binding proteins |
US5202422A (en) * | 1989-10-27 | 1993-04-13 | The Scripps Research Institute | Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use |
EP0438312A3 (en) * | 1990-01-19 | 1992-07-01 | Merck & Co. Inc. | Recombinant human anti-cd18 antibodies |
US5143905A (en) * | 1990-05-03 | 1992-09-01 | The Regents Of The University Of California | Method and means for extending the host range of insecticidal proteins |
US5665595A (en) * | 1991-06-07 | 1997-09-09 | Dowelanco | Immunoglobulins against insect tissue |
ATE133264T1 (de) * | 1991-07-25 | 1996-02-15 | Ciba Geigy Ag | Immunologisches nachweisverfahren |
-
1995
- 1995-05-16 US US08/442,542 patent/US5686600A/en not_active Expired - Fee Related
- 1995-06-20 CN CN95193817A patent/CN1151759A/zh active Pending
- 1995-06-20 JP JP8502979A patent/JPH11505401A/ja active Pending
- 1995-06-20 CA CA002193859A patent/CA2193859A1/en not_active Abandoned
- 1995-06-20 US US08/765,469 patent/US6069301A/en not_active Expired - Fee Related
- 1995-06-20 HU HU9603526A patent/HUT76089A/hu unknown
- 1995-06-20 SK SK1669-96A patent/SK166996A3/sk unknown
- 1995-06-20 WO PCT/IB1995/000497 patent/WO1996000783A1/en not_active Application Discontinuation
- 1995-06-20 NZ NZ287124A patent/NZ287124A/en unknown
- 1995-06-20 MX MX9700007A patent/MX9700007A/es unknown
- 1995-06-20 PL PL95318164A patent/PL318164A1/xx unknown
- 1995-06-20 EE EE9600192A patent/EE9600192A/xx unknown
- 1995-06-20 AU AU25735/95A patent/AU696661B2/en not_active Ceased
- 1995-06-20 BR BR9508154A patent/BR9508154A/pt not_active Application Discontinuation
- 1995-06-20 EP EP95920192A patent/EP0804579A1/en not_active Withdrawn
- 1995-06-20 CZ CZ963821A patent/CZ382196A3/cs unknown
-
1997
- 1997-01-24 BG BG101171A patent/BG101171A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US6069301A (en) | 2000-05-30 |
EP0804579A1 (en) | 1997-11-05 |
CZ382196A3 (cs) | 1998-03-18 |
AU696661B2 (en) | 1998-09-17 |
US5686600A (en) | 1997-11-11 |
NZ287124A (en) | 1999-04-29 |
SK166996A3 (en) | 1997-08-06 |
HUT76089A (en) | 1997-06-30 |
MX9700007A (es) | 1997-04-30 |
CA2193859A1 (en) | 1996-01-11 |
WO1996000783A1 (en) | 1996-01-11 |
CN1151759A (zh) | 1997-06-11 |
PL318164A1 (en) | 1997-05-26 |
JPH11505401A (ja) | 1999-05-21 |
EE9600192A (et) | 1997-06-16 |
AU2573595A (en) | 1996-01-25 |
BG101171A (en) | 1997-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9508154A (pt) | Anticorpos que se ligam ás proteínas de tripa de inseto e uso dos mesmos | |
FI963185A (fi) | Hematopoieettinen proteiini ja materiaalit ja menetelmät sen valmistamiseksi | |
FI951801A (fi) | CTLA4-molekyylit ja IL4:sitovat molekyylit sekä näiden käyttö | |
DE29517190U1 (de) | Analyse- und Dosiersystem | |
FI962377A0 (fi) | Humanisoituja vasta-aineita ja niiden käyttö | |
DE69532847D1 (de) | System zur Seitenanalyse | |
NO991449L (no) | Antistoff mot human parathormon-relaterte peptider | |
PT941056E (pt) | Composicoes de esfingomielinase e sua utilizacao | |
BR9610109A (pt) | Fecho e uso mesmo | |
DE69531958D1 (de) | (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper | |
FI952069A (fi) | Vähäallergeeniset proteiinit | |
FI963288A0 (fi) | Fibriinispesifinen vasta-aine käytettäväksi veritulppia estävänä aineena | |
DE69312185D1 (de) | Chromatographischer Sandwichtest zur Bestimmung von spezifischen Antikörpern und Vorrichtung hierfür | |
DE3888604D1 (de) | Monoklonale Antikörper gegen Antithrombinbindende Substanz und seine Verwendungen. | |
DK94091D0 (da) | Hdl-bindende proteiner | |
FI960167A0 (fi) | Sydänlihaskuolion osoittaminen immuunimäärityksellSydänlihaskuolion osoittaminen immuunimäärityksellä ja siihen sopivat vasta-aineet ä ja siihen sopivat vasta-aineet | |
TR199701666A3 (tr) | Sismanliga karsi proteinler | |
FI952108A0 (fi) | Fibronnektiiniä sitova proteiini sekä sen valmistaminen | |
FI971086A (fi) | Kinaasia sitova proteiini ja sen käyttö | |
BR9600791A (pt) | Composto processo para sua preparação composições herbicidas processo para combater ervas e uso | |
EE9900092A (et) | PTX-tundlikud G-valgud, nende valmistamine ja kasutamine | |
BR9509973A (pt) | Corantes de benzopirano compostos e uso dos corantes de benzopirano | |
DE19581354T1 (de) | Verbesserungen von Kraftmaschinen | |
BR9602779A (pt) | Cis-n-propenil-acetamidas n-substituídas processo para sua preparação e uso | |
DE69718579D1 (de) | Bestimmung von Proteinen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer |
Free format text: NOVARTIS AG (NOVARTIS SA) (NOVARTIS INC.) (CH) |
|
EG | Technical examination (opinion): publication of technical examination (opinion) | ||
FC | Decision: refusal |